California Institute for Regenerative Medicine ( CIRM)

Primary tabs

CIRM's picture

Management

Contact Address

About California Institute for Regenerative Medicine

"To support and advance stem cell research and regenerative medicine under the highest ethical and medical standards for the discovery and development of cures, therapies, diagnostics and research technologies to relieve human suffering from chronic disease and injury."

CIRM press release, blog etc

Thu, 05/29/2025 - 17:52 CIRM awards $4.7 million for vision loss gene therapy
Thu, 04/24/2025 - 18:09 CIRM awards $8 million to advance vision loss gene therapy to clinical trials
Fri, 06/28/2024 - 18:01 CIRM awards $26 million to advance clinical research across cancer, heart conditions, and rare diseases
Tue, 08/30/2022 - 17:19 Stem Cell Agency Invests $46 Million in New Education Program
Tue, 08/23/2022 - 15:31 Stem Cell Agency Expands Industry Alliance Program to Accelerate Therapies
Thu, 06/16/2022 - 10:31 Stem Cell Agency Joins Consortium Developing Gene Therapies for Rare Diseases
Mon, 02/14/2022 - 11:26 CIRM-Funded Study Helping Babies Battle a Deadly Immune Disorder Gets Boost from FDA
Fri, 01/21/2022 - 14:04 California Institute for Regenerative Medicine and the Davos Alzheimers Collaborative Release a Statement of Interest to Advance Brain Research
Tue, 11/23/2021 - 13:53 Stem Cell Agency Board Invests in Therapy Targeting Deadly Blood Cancers
Tue, 10/19/2021 - 18:18 Stem Cell Agency Funds Research to Repair Damaged Knee Cartilage
Thu, 09/23/2021 - 03:49 Stem Cell Agency Funds Clinical Trial Targeting Blood Cancers in Children and Young Adults
Mon, 08/23/2021 - 19:14 Stem Cell Agency Funds Three New Clinical Trials at Stanford
Tue, 07/20/2021 - 09:40 Board Funds Fifteen Bridges to Stem Cell Research and Therapy Programs Across California and New Sickle Cell Disease Trial
Tue, 07/06/2021 - 21:36 Art Torres Appointed to Two New Roles on the University of California Board of Regents
Fri, 06/18/2021 - 09:25 CIRM Board Approves New Clinical Trial for ALS
Mon, 05/17/2021 - 10:30 CIRM Board Approves Continued Funding for SPARK and Alpha Stem Cell Clinics
Fri, 05/14/2021 - 08:02 Industry Executive Kevin Marks joins CIRM as General Counsel during the Agencys first wave of strategic growth
Wed, 05/12/2021 - 08:29 Medeor Therapeutics Completes Enrollment in CIRM-Funded Clinical Trial for Kidney Transplant Patients